Literature DB >> 12049732

The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2.

Zhimin Lu1, Shuichan Xu, Claudio Joazeiro, Melanie H Cobb, Tony Hunter.   

Abstract

ERK1/2 MAP kinases are important regulators in cellular signaling, whose activity is normally reversibly regulated by threonine-tyrosine phosphorylation. In contrast, we have found that stress-induced ERK1/2 activity is downregulated by ubiquitin/proteasome-mediated degradation of ERK1/2. The PHD domain of MEKK1, a RING finger-like structure, exhibited E3 ubiquitin ligase activity toward ERK2 in vitro and in vivo. Moreover, both MEKK1 kinase activity and the docking motif on ERK1/2 were involved in ERK1/2 ubiquitination. Significantly, cells expressing ERK2 with the docking motif mutation were resistant to sorbitol-induced apoptosis. Therefore, MEKK1 functions not only as an upstream activator of the ERK and JNK through its kinase domain, but also as an E3 ligase through its PHD domain, providing a negative regulatory mechanism for decreasing ERK1/2 activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049732     DOI: 10.1016/s1097-2765(02)00519-1

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  111 in total

1.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Oxidative neuronal injury. The dark side of ERK1/2.

Authors:  Charleen T Chu; David J Levinthal; Scott M Kulich; Elisabeth M Chalovich; Donald B DeFranco
Journal:  Eur J Biochem       Date:  2004-06

3.  Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.

Authors:  Ido Amit; Liat Yakir; Menachem Katz; Yaara Zwang; Mina D Marmor; Ami Citri; Keren Shtiegman; Iris Alroy; Shmuel Tuvia; Yuval Reiss; Eli Roubini; Maya Cohen; Ron Wides; Eran Bacharach; Ullrich Schubert; Yosef Yarden
Journal:  Genes Dev       Date:  2004-07-15       Impact factor: 11.361

Review 4.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

5.  Activity of a C-terminal plant homeodomain (PHD) of Msc1 is essential for function.

Authors:  Xinxing Qiu; Barbara E Dul; Nancy C Walworth
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

Review 6.  The various roles of ubiquitin in Wnt pathway regulation.

Authors:  Daniele V F Tauriello; Madelon M Maurice
Journal:  Cell Cycle       Date:  2010-09-25       Impact factor: 4.534

7.  MEKK1 mediates the ubiquitination and degradation of c-Jun in response to osmotic stress.

Authors:  Yan Xia; Ji Wang; Shuichan Xu; Gary L Johnson; Tony Hunter; Zhimin Lu
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

8.  T-cell regulator RNF125/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain.

Authors:  Ana Lucia Giannini; Yifang Gao; Marie-José Bijlmakers
Journal:  Biochem J       Date:  2008-02-15       Impact factor: 3.857

9.  c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.

Authors:  Qiangrong Liang; Orlando F Bueno; Benjamin J Wilkins; Chia-Yi Kuan; Ying Xia; Jeffery D Molkentin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

10.  A novel protein with similarities to Rb binding protein 2 compensates for loss of Chk1 function and affects histone modification in fission yeast.

Authors:  Shakil Ahmed; Carmela Palermo; Shanhong Wan; Nancy C Walworth
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.